These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27190429)

  • 1. MUC1 Immunohistochemical Expression as a Prognostic Factor in Gastric Cancer: Meta-Analysis.
    Wang XT; Kong FB; Mai W; Li L; Pang LM
    Dis Markers; 2016; 2016():9421571. PubMed ID: 27190429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis.
    Akyürek N; Akyol G; Dursun A; Yamaç D; Günel N
    Pathol Res Pract; 2002; 198(10):665-74. PubMed ID: 12498221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas.
    Wang JY; Chang CT; Hsieh JS; Lee LW; Huang TJ; Chai CY; Lin SR
    J Surg Oncol; 2003 Aug; 83(4):253-60. PubMed ID: 12884239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.
    Tamura Y; Higashi M; Kitamoto S; Yokoyama S; Osako M; Horinouchi M; Shimizu T; Tabata M; Batra SK; Goto M; Yonezawa S
    PLoS One; 2012; 7(11):e49251. PubMed ID: 23152882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
    Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
    Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
    Xiong ZF; Xiao H; Tan YS
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma.
    Reis CA; David L; Seixas M; Burchell J; Sobrinho-Simões M
    Int J Cancer; 1998 Aug; 79(4):402-10. PubMed ID: 9699534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures.
    Wang XT; Wei WY; Kong FB; Lian C; Luo W; Xiao Q; Xie YB
    J Exp Clin Cancer Res; 2012 Nov; 31(1):98. PubMed ID: 23181722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
    Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
    Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.
    Retterspitz MF; Mönig SP; Schreckenberg S; Schneider PM; Hölscher AH; Dienes HP; Baldus SE
    Anticancer Res; 2010 Nov; 30(11):4635-41. PubMed ID: 21115917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
    Tanaka M; Kitajima Y; Sato S; Miyazaki K
    Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.
    Hamada T; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
    Cancer; 2012 Nov; 118(21):5251-64. PubMed ID: 22434549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the expression of MUC1 and collagen type IV in advanced gastric carcinoma.
    Ando H; Aihara R; Ohno T; Ogata K; Mochiki E; Kuwano H
    Br J Surg; 2009 Aug; 96(8):901-9. PubMed ID: 19591170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III.
    Shinozaki E; Adachi S; Shoda J; Kawamoto T; Suzuki H; Irimura T; Ohkohchi N
    Int J Oncol; 2004 Nov; 25(5):1257-65. PubMed ID: 15492813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
    Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer.
    Ohno T; Aihara R; Kamiyama Y; Mochiki E; Asao T; Kuwano H
    Eur J Cancer; 2006 Jan; 42(2):256-63. PubMed ID: 16356709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of E-cadherin in gastric cancer: a meta-analysis.
    Xing X; Tang YB; Yuan G; Wang Y; Wang J; Yang Y; Chen M
    Int J Cancer; 2013 Jun; 132(11):2589-96. PubMed ID: 23169395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma.
    Nakagawa K; Akagi J; Takai E; Tamori Y; Okino T; Kako H; Egami H; Ogawa M
    Int J Oncol; 1999 Mar; 14(3):425-35. PubMed ID: 10024673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.